Start Codon aims to rapidly translate the most disruptive and innovative life science research into successful companies and positive clinical outcomes The first cohort of four companies will debut at ...

CAMBRIDGE, England--(BUSINESS WIRE)--Start Codon, a new strategic initiative aimed at driving the translation of world-class research into commercially successful companies, has been founded and ...

In a new study, researchers at the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs' ...

Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million. The Fund will be used to ...